L. Grunebaum

5.6k total citations · 1 hit paper
82 papers, 3.8k citations indexed

About

L. Grunebaum is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, L. Grunebaum has authored 82 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 26 papers in Internal Medicine and 22 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in L. Grunebaum's work include Venous Thromboembolism Diagnosis and Management (26 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and COVID-19 Clinical Research Studies (12 papers). L. Grunebaum is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (26 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and COVID-19 Clinical Research Studies (12 papers). L. Grunebaum collaborates with scholars based in France, Switzerland and United States. L. Grunebaum's co-authors include Laurent Sattler, Ferhat Meziani, Julie Helms, Mickaël Ohana, François Séverac, Francis Schneider, Ian Léonard-Lorant, Raphaël Clère-Jehl, Paul‐Michel Mertès and Vincent Castelain and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.

In The Last Decade

L. Grunebaum

81 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

2020 1.9k citations Julie Helms, Charles Tacquard et al. profile →

Peers

Countries citing papers authored by L. Grunebaum

Since Specialization

Citations

This map shows the geographic impact of L. Grunebaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Grunebaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Grunebaum more than expected).

Fields of papers citing papers by L. Grunebaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Grunebaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Grunebaum. The network helps show where L. Grunebaum may publish in the future.

Co-authorship network of co-authors of L. Grunebaum

This figure shows the co-authorship network connecting the top 25 collaborators of L. Grunebaum. A scholar is included among the top collaborators of L. Grunebaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Grunebaum. L. Grunebaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Study of Modifications Induced by Continued Direct Oral Anticoagulant Therapy during Atrial Fibrillation Ablation Procedures on Standard Hemostasis Parameters 2023 ·Journal of Clinical Medicine ·(unknown), Julien Godet, Xavier Delabranche, Laurent Sattler, (unknown), Halim Marzak, Paul‐Michel Mertès, A. Steib, L. Grunebaum, Laurence Jesel, Charles Tacquard	1
2	P2Y12 inhibition by clopidogrel increases adverse clinical events after transcatheter aortic valve replacement 2022 ·International Journal of Cardiology ·Kensuke Matsushita, Benjamin Marchandot, Marion Kibler, (unknown), (unknown), Antonin Trimaille, Sébastien Hess, L. Grunebaum, Mickaël Ohana, Antje Reydel, Laurence Jesel, Patrick Ohlmann, Olivier Morel	1
3	Venous thromboembolism in non-critically ill patients with COVID-19 infection 2021 ·Archives of Cardiovascular Diseases Supplements ·Antonin Trimaille, Anaïs Curtiaud, Benjamin Marchandot, Kensuke Matsushita, Chika Sato, Ian Léonard-Lorant, Laurent Sattler, L. Grunebaum, Mickaël Ohana, (unknown), Emmanuel Andrès, Bernard Goichot, François Danion, Charlotte Kaeuffer, Vincent Poindron, Patrick Ohlmann, Laurence Jesel, Olivier Morel	6
4	Microparticles in COVID-19 as a link between lung injury extension and thrombosis 2021 ·ERJ Open Research ·Olivier Morel, Benjamin Marchandot, Laurence Jesel, Laurent Sattler, Antonin Trimaille, Anaïs Curtiaud, Mickaël Ohana, Samira Fafi‐Kremer, Valérie B. Schini‐Kerth, L. Grunebaum, Jean‐Marie Freyssinet	5
5	Transient endothelial injury and release of lupus anticoagulant in COVID-19 2021 ·Archives of Cardiovascular Diseases Supplements ·Antonin Trimaille, Benjamin Marchandot, Walid Oulehri, Adrien Carmona, (unknown), Vincent Poindron, Kensuke Matsushita, Laurent Sattler, L. Grunebaum, Anne‐Sophie Korganow, (unknown), Olivier Morel	1
6	D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients 2020 ·Journal of Clinical Medicine ·Antonin Trimaille, Jecko Thachil, Benjamin Marchandot, Anaïs Curtiaud, Ian Léonard-Lorant, Adrien Carmona, Kensuke Matsushita, Chisato Sato, Laurent Sattler, L. Grunebaum, Yves Hansmann, Samira Fafi‐Kremer, Laurence Jesel, Mickaël Ohana, Olivier Morel	19
7	Switching toward the use of recombinant factor VIII Fc fusion proteinStudy among 30 patients with severe hemophilia A 2020 ·Annales de biologie clinique ·Laurent Sattler, (unknown), (unknown), (unknown), Olivier Feugeas, L. Grunebaum, Dominique Desprez	3
8	Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial 2015 ·Critical Care ·B. Tardy-Poncet, Philippe Nguyên, (unknown), Pierre‐Emmanuel Morange, Christine Biron‐Andréani, Yves Gruel, Jérôme Morel, Alain Wynckel, L. Grunebaum, (unknown), Sandrine Grosjean, Emmanuel de Maistre	42
9	0137: Endothelial-derived microparticles contribute to disseminated intravascular coagulopathy during septic shock 2014 ·Archives of Cardiovascular Diseases Supplements ·Xavier Delabranche, Julie Helms, Pierre Asfar, (unknown), Fatiha Zobairi, Thierry Lavigne, L. Grunebaum, Florence Toti, Ferhat Meziani, Y. Mootien	1
10	Clinical characteristics and laboratory testing of patients with suspected HIT: A survey on current practice in 11 university hospitals in France 2010 ·Thrombosis Research ·Audrey Bidet, (unknown), Dominique Desprez, Emmanuel de Maistre, Émilie Presles, Thomas Lecompte, Cécile Lavenu‐Bombled, (unknown), Martine Wolf, Pierre‐Emmanuel Morange, E Racadot, C. Mouton, L. Grunebaum, Claire Pouplard, Bernard Tardy	6
11	Facteurs prédictifs de l’existence d’une ischémie myocardique silencieuse chez le patient diabétique. Intérêt de l’évaluation de la surface de l’oreillette gauche 2008 ·Annales de Cardiologie et d Angéiologie ·Bruno Pereira, Olivier Morel, (unknown), L. Grunebaum, Bernard Goichot, (unknown), Laurence Jesel, A. Faure, (unknown), S. Vinzio, André Constantinesco, (unknown)	5
12	Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension 2007 ·American Journal of Respiratory and Critical Care Medicine ·Babé Bakouboula, Olivier Morel, A. Faure, Fatiha Zobairi, Laurence Jesel, Annie Trinh, Michel Zupan, Matthieu Canuet, L. Grunebaum, (unknown), Dominique Desprez, F. Chabot, E Weitzenblum, Jean‐Marie Freyssinet, Ari Chaouat, Florence Toti	144
13	Circulating procoagulant microparticles in obesity 2006 ·Diabetes & Metabolism ·Bernard Goichot, L. Grunebaum, Dominique Desprez, S. Vinzio, Laurence Meyer, J.-L. Schlienger, Martin Lessard, Chantal Simon	78
14	Diagnostic and prognostic value of circulating D-Dimers in patients with acute aortic dissection 2006 ·Critical Care Medicine ·Patrick Ohlmann, A. Faure, Olivier Morel, Hélène Petit, (unknown), Nicolás Meyer, Édouard Cheneau, Laurence Jesel, Éric Epailly, Dominique Desprez, L. Grunebaum, Francis Schneider, G Roul, (unknown), Bernard Eisenmann, P Bareiss	122
15	Variabilité de la réponse plaquettaire au clopidogrel : « résistance » biologique ? 2005 ·Annales de Cardiologie et d Angéiologie ·Olivier Morel, Patrick Ohlmann, Laurence Jesel, N. Morel, (unknown), A. Faure, L. Grunebaum, Florence Toti, (unknown)	1
16	[Influence of protein S deficiency on the arterial thrombosis risk]. 1991 ·PubMed ·(unknown), J.Y. Borg, L. Grunebaum, Marc Vasse, H. Lévesque, R Biermé, Piérre Siè	14
17	DNA amplification of HIV genome in hemophiliacs and in newborns from seropositive mothers 1991 ·Annals of Hematology ·C de la Salle, (unknown), (unknown), B. Guy, (unknown), Ronald A. Asherson, L. Grunebaum, Philipp Lutz, Marialuisa Partisani, Jean-Marie Lang, (unknown), Jean‐Pierre Cazenave	2
18	Potential thrombogenicity of angiographic contrast agents 1991 ·Thrombosis Research ·(unknown), Michel Zupan, (unknown), L. Grunebaum, C Brechenmacher, Jean‐Pierre Cazenave	4
19	The catalytic role of anionic phospholipids in the activation of protein C by factor Xa and expression of its anticoagulant function in human plasma 1991 ·Blood Coagulation & Fibrinolysis ·J.-M. Freyssinet, (unknown), Catherine Ravanat, L. Grunebaum, (unknown), Jean‐Pierre Cazenave, Ronald A. Asherson	16
20	Screening of protein S deficiency using a functional assay in patients with venous and arterial thrombosis 1990 ·Thrombosis Research ·(unknown), (unknown), (unknown), L. Grunebaum, Simone Schuhler, Jean‐Pierre Cazenave	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact